{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,7]],"date-time":"2026-01-07T13:07:33Z","timestamp":1767791253084,"version":"3.49.0"},"reference-count":30,"publisher":"MDPI AG","issue":"1","license":[{"start":{"date-parts":[[2026,1,7]],"date-time":"2026-01-07T00:00:00Z","timestamp":1767744000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100005297","name":"Medical University of Bialystok","doi-asserted-by":"publisher","award":["SUB\/1\/DN\/22\/001\/1149"],"award-info":[{"award-number":["SUB\/1\/DN\/22\/001\/1149"]}],"id":[{"id":"10.13039\/501100005297","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Metabolites"],"abstract":"<jats:p>Background: Psoriasis is a chronic, immune-mediated skin disorder characterized by accelerated epidermal turnover. Galectins are a family of carbohydrate-binding proteins that play crucial roles in various biological processes. Methods: This study aimed to assess the plasma concentrations of galectin 7 and 8 (gal-7 and 8) in 60 psoriatic patients compared to the control group of 30 individuals without dermatoses. Results: The median gal-7 plasma concentration in patients was 188.8 (11.43\u20131406) pg\/mL, and it was significantly higher than in controls (p &lt; 0.001). There was a positive correlation between gal-7 concentration and psoriasis area and severity index (PASI; R = 0.3, p = 0.0199), and a negative with RBC (R = \u22120.41, p &lt; 0.001), hemoglobin concentration (R = \u22120.34, p &lt; 0.01), total cholesterol (R = \u22120.38, p &lt; 0.01) and LDL concentration (R = \u22120.36, p &lt; 0.05). In contrast, gal-7 was not correlated with psoriasis duration or patients\u2019 age or sex (p &gt; 0.05). The median gal-8 plasma concentration in patients was 0.07 (0.02\u20130.5) ng\/mL, and was significantly higher in patients than controls (p &lt; 0.05). There was a positive correlation between gal-8 concentration and glucose concentration (R = 0.26, p &lt; 0.05). Gal-8 concentration was not correlated with PASI, BMI, age or sex of patients (p &gt; 0.05). We also analyzed the receiver operating characteristic (ROC) curve to evaluate the predictive power of gal-7 and 8 for psoriasis. Gal-7 achieved statistical significance in predicting psoriasis and had an area under the curve (AUC) value of 0.842 (p &lt; 0.001), a sensitivity of 80%, and a specificity of 86.7%, whereas gal-8 had an AUC value of 0.644 (p = 0.025), a sensitivity of 81%, and a specificity of 47%. Conclusions: Gal-7 and gal-8 could potentially serve as psoriasis biomarkers, whereby gal-7 could also serve as a marker of its severity. Future studies are needed to clarify their actual role or potential as therapeutic targets in psoriasis. Understanding their precise functions may open new perspectives for personalized treatment strategies in psoriatic patients.<\/jats:p>","DOI":"10.3390\/metabo16010050","type":"journal-article","created":{"date-parts":[[2026,1,7]],"date-time":"2026-01-07T08:26:56Z","timestamp":1767774416000},"page":"50","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Plasma Galectin-7 (Gal-7) and Galectin-8 (Gal-8) as Emerging Biomarkers in Psoriasis: Associations with Disease Activity and Metabolic Status"],"prefix":"10.3390","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6870-1167","authenticated-orcid":false,"given":"Julia","family":"Nowowiejska-Purpurowicz","sequence":"first","affiliation":[{"name":"Department of Dermatology and Venereology, Medical University of Bialystok, Zurawia 14 St., 15-540 Bialystok, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8018-9960","authenticated-orcid":false,"given":"Anna","family":"Baran","sequence":"additional","affiliation":[{"name":"Department of Dermatology and Venereology, Medical University of Bialystok, Zurawia 14 St., 15-540 Bialystok, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3985-4244","authenticated-orcid":false,"given":"Justyna Magdalena","family":"Hermanowicz","sequence":"additional","affiliation":[{"name":"Department of Pharmacodynamics, Medical University of Bialystok, Mickiewicza 2C St., 15-222 Bialystok, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Beata","family":"Sieklucka","sequence":"additional","affiliation":[{"name":"Department of Monitored Pharmacotherapy, Medical University of Bialystok, Mickiewicza 2C St., 15-222 Bialystok, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2254-7982","authenticated-orcid":false,"given":"Krystyna","family":"Pawlak","sequence":"additional","affiliation":[{"name":"Department of Monitored Pharmacotherapy, Medical University of Bialystok, Mickiewicza 2C St., 15-222 Bialystok, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3751-0608","authenticated-orcid":false,"given":"Dariusz","family":"Pawlak","sequence":"additional","affiliation":[{"name":"Department of Pharmacodynamics, Medical University of Bialystok, Mickiewicza 2C St., 15-222 Bialystok, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5923-910X","authenticated-orcid":false,"given":"Iwona","family":"Flisiak","sequence":"additional","affiliation":[{"name":"Department of Dermatology and Venereology, Medical University of Bialystok, Zurawia 14 St., 15-540 Bialystok, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2026,1,7]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","unstructured":"Rendon, A., and Sch\u00e4kel, K. (2019). Psoriasis Pathogenesis and Treatment. Int. J. Mol. Sci., 20.","DOI":"10.3390\/ijms20061475"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1001\/jama.2020.4006","article-title":"Pathophysiology, Clinical Presentation, and Treatment of Psoriasis","volume":"323","author":"Armstrong","year":"2020","journal-title":"JAMA"},{"key":"ref_3","doi-asserted-by":"crossref","unstructured":"Wei, J., Wang, Y., Chen, Y., Wang, Z., Dai, X., Gelfand, J.M., Bachelez, H., Chen, X., Xiao, Y., and Shen, M. (2025). Global Burden of Psoriasis from 1990 to 2021 and Potential Factors: A Systematic Analysis. J. Investig. Dermatol., Epub ahead of print.","DOI":"10.1016\/j.jid.2025.08.038"},{"key":"ref_4","doi-asserted-by":"crossref","unstructured":"Wang, L., Liu, R., Tang, Y., Ma, Y., Wang, G., Ruan, Q., and Zheng, S.J. (2025). Advances in Psoriasis Research: Decoding Immune Circuits and Developing Novel Therapies. Int. J. Mol. Sci., 26.","DOI":"10.20944\/preprints202508.1767.v1"},{"key":"ref_5","unstructured":"Varki, A., Cummings, R.D., Esko, J.D., Freeze, H.H., Stanley, P., Bertozzi, C.R., Hart, G.W., and Etzler, M.E. (2025, September 20). Galectins, Essentials of Glycobiology, Available online: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK1944\/."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1186\/s40364-025-00759-1","article-title":"Multifaceted roles of Galectins: From carbohydrate binding to targeted cancer therapy","volume":"13","author":"Zhang","year":"2025","journal-title":"Biomark. Res."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"2236","DOI":"10.1002\/med.22041","article-title":"Galectin-8 inhibition and functions in immune response and tumor biology","volume":"44","author":"Nilsson","year":"2024","journal-title":"Med. Res. Rev."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1038\/JID.2015.366","article-title":"Galectin-7 Regulates Keratinocyte Proliferation and Differentiation through JNK-miR-203-p63 Signaling","volume":"136","author":"Chen","year":"2016","journal-title":"J. Investig. Dermatol."},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"Horie, A., Miyagaki, T., Hiranuma, C., Iijima, M., Hara, Y., Oba, S., Hashimoto, M., Omori, R., Okano, T., and Kadono, T. (2025). Clinical Effectiveness, Clinical Stability, and Effects on Serum Galectin-7 Levels of Dupilumab and JAK Inhibitors in Moderate-to-Severe Atopic Dermatitis: A Real-World, Single-Center Analysis. Medicina, 61.","DOI":"10.3390\/medicina61050926"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1038\/s41418-022-01108-7","article-title":"Galectin-7 reprograms skin carcinogenesis by fostering innate immune evasive programs","volume":"30","author":"Pinto","year":"2023","journal-title":"Cell Death Differ."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1042\/BST20200677","article-title":"Galectin-8, cytokines, and the storm","volume":"50","author":"Zick","year":"2022","journal-title":"Biochem. Soc. Trans."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1146\/annurev-immunol-032713-120225","article-title":"Immunology of psoriasis","volume":"32","author":"Lowes","year":"2014","journal-title":"Annu. Rev. Immunol."},{"key":"ref_13","first-page":"S0022-202X(25)02330-9","article-title":"Galectins in Inflammatory Skin Diseases: Mechanisms and Therapeutic Potential","volume":"8","author":"Danesh","year":"2025","journal-title":"J. Investig. Dermatol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"110741","DOI":"10.1016\/j.humimm.2023.110741","article-title":"The elevation of plasma galectin-9 levels in patients with psoriasis and its associations with inflammatory and immune checkpoint molecules in skin tissues","volume":"85","author":"He","year":"2024","journal-title":"Hum. Immunol."},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"Nowowiejska, J., Baran, A., Hermanowicz, J.M., Sieklucka, B., Pawlak, D., and Flisiak, I. (2023). Evaluation of Plasma Concentrations of Galectins-1, 2 and 12 in Psoriasis and Their Clinical Implications. Biomolecules, 13.","DOI":"10.3390\/biom13101472"},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"Baran, A., Kiluk, P., Nowowiejska, J., Kaminski, T.W., Maciaszek, M., and Flisiak, I. (2022). Galectin-3 as a Novel Multifaceted and Not Only Cardiovascular Biomarker in Patients with Psoriasis with Regard to Systemic Treatment\u2014Preliminary Data. Biology, 11.","DOI":"10.3390\/biology11010088"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"10339","DOI":"10.3390\/ijms262110339","article-title":"Plasma Galectin-4 and Charcot-Leyden Crystal Protein\/Galectin-10 as Emerging Biomarkers of Metabolically Induced Inflammation in Patients with Psoriasis","volume":"26","author":"Baran","year":"2025","journal-title":"Int. J. Mol. Sci."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"e130740","DOI":"10.1172\/JCI130740","article-title":"Galectin-7 downregulation in lesional keratinocytes contributes to enhanced IL-17A signaling and skin pathology in psoriasis","volume":"131","author":"Chen","year":"2021","journal-title":"J. Clin. Investig."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"5541","DOI":"10.1091\/mbc.e08-02-0166","article-title":"Galectin-7 in the control of epidermal homeostasis after injury","volume":"19","author":"Gendronneau","year":"2008","journal-title":"Mol. Biol. Cell"},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"Frantz, R., Huang, S., Are, A., and Motaparthi, K. (2021). Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis: A Review of Diagnosis and Management. Medicina, 57.","DOI":"10.3390\/medicina57090895"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1016\/j.jaci.2012.06.044","article-title":"Comparative transcriptomic analyses of atopic dermatitis and psoriasis reveal shared neutrophilic inflammation","volume":"130","author":"Choy","year":"2012","journal-title":"J. Allergy Clin. Immunol."},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"Stuart, C.M., Jacob, C., Varatharaj, A., Howard, S., Chouhan, J.K., Teeling, J.L., and Galea, I. (2024). Mild Systemic Inflammation Increases Erythrocyte Fragility. Int. J. Mol. Sci., 25.","DOI":"10.3390\/ijms25137027"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"e37360","DOI":"10.1097\/MD.0000000000037360","article-title":"Oxidative stress\u2019s impact on red blood cells: Unveiling implications for health and disease","volume":"103","author":"Obeagu","year":"2024","journal-title":"Medicine"},{"key":"ref_24","doi-asserted-by":"crossref","unstructured":"Carvalho, L.V.d.N., Assis, R.A., Montenegro, C., da Rosa, M.M., Pereira, M.C., Pitta, M.G.d.R., and de Melo R\u00eago, M.J.B. (2024). Galectin Plasmatic Levels Reveal a Cluster Associated with Disease Aggressiveness and Kidney Damage in Multiple Myeloma Patients. Int. J. Mol. Sci., 25.","DOI":"10.3390\/ijms252413499"},{"key":"ref_25","unstructured":"Feingold, K.R., Ahmed, S.F., Anawalt, B., Blackman, M.R., Chrousos, G., Corpas, E., de Herder, W.W., Dhatariya, K., Dungan, K., and Hamilton, E. (2025, September 20). Effect of Inflammation and Infection on Lipids and Lipoproteins. [Updated 2025 Jun 18], Endotext [Internet], Available online: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK326741\/."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1194\/jlr.R300019-JLR200","article-title":"Effects of infection and inflammation on lipid and lipoprotein metabolism: Mechanisms and consequences to the host","volume":"45","author":"Khovidhunkit","year":"2004","journal-title":"J. Lipid Res."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/j.jid.2020.07.021","article-title":"Galectin-8 Is Upregulated in Keratinocytes by IL-17A and Promotes Proliferation by Regulating Mitosis in Psoriasis","volume":"141","author":"Lo","year":"2021","journal-title":"J. Investig. Dermatol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1007\/s00403-006-0703-z","article-title":"Increased prevalence of the metabolic syndrome in patients with moderate to severe psoriasis","volume":"298","author":"Sommer","year":"2006","journal-title":"Arch. Dermatol. Res."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1016\/j.dsx.2019.01.009","article-title":"The association between psoriasis and diabetes mellitus: A systematic review and meta-analysis","volume":"13","author":"Mamizadeh","year":"2019","journal-title":"Diabetes Metab. Syndr. Clin. Res. Rev."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.jaad.2017.10.050","article-title":"Psoriasis and the risk of diabetes: A prospective population-based cohort study","volume":"78","author":"Wan","year":"2018","journal-title":"J. Am. Acad. Dermatol."}],"container-title":["Metabolites"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2218-1989\/16\/1\/50\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,7]],"date-time":"2026-01-07T08:44:17Z","timestamp":1767775457000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2218-1989\/16\/1\/50"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,7]]},"references-count":30,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,1]]}},"alternative-id":["metabo16010050"],"URL":"https:\/\/doi.org\/10.3390\/metabo16010050","relation":{},"ISSN":["2218-1989"],"issn-type":[{"value":"2218-1989","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,7]]}}}